What is Liberum?
Liberum operates at the intersection of synthetic biology and high-throughput discovery, leveraging a proprietary cell-free protein synthesis platform to accelerate the development of enzymes and antibodies. By bypassing traditional, time-intensive cellular expression methods, the company provides a streamlined pipeline for pharmaceutical and industrial biotech partners. This technological edge positions Liberum as a critical enabler in the drug discovery ecosystem, effectively reducing the latency between molecular design and functional validation. As the firm transitions from its initial seed-stage development, its focus remains on optimizing its synthesis platform to meet the rigorous demands of enterprise-level research and development cycles.
How much funding has Liberum raised?
Liberum has raised a total of $1.8M across 1 funding round:
Angel/Seed
$1.8M
Angel/Seed (2023): $1.8M with participation from Savantus Ventures and SOSV
Key Investors in Liberum
Savantus Ventures
Savantus Ventures is a venture capital firm based in Nyack, New York, that focuses on providing strategic financial support to emerging companies.
SOSV
SOSV is a prominent multi-stage venture capital investor known for providing both intellectual and financial capital to accelerate the growth of high-potential startups.
What's next for Liberum?
The infusion of capital will likely be directed toward scaling the company's synthesis capacity and expanding its commercial footprint within the global biotech sector. Given the current major strategic investment, Liberum is expected to prioritize the refinement of its automated workflows and the acquisition of key talent to support its growing client base. Future milestones will likely involve the expansion of its intellectual property portfolio and the establishment of strategic partnerships with major pharmaceutical entities, further cementing its role as a foundational player in the next generation of protein engineering. The company's ability to maintain its technical lead while scaling operations will be the primary metric for its long-term success in this competitive landscape.
See full Liberum company page
